Pierluigi L. Viale
St Orsola Malpighi University Hospital
Bologna, Italy
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 519 publications
Correction to: Modern and multidisciplinary care in polycythemia vera.
Journal: Annals of hematology
Published: July 25, 2026
Isavuconazole as primary antifungal prophylaxis in pediatric hematological patients: a clinical and pharmacokinetic analysis.
Journal: Antimicrobial agents and chemotherapy
Published: June 26, 2026
Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia.
Journal: Journal of medical microbiology
Published: April 10, 2026
Is residual diuresis a reliable proxy of creatinine clearance for titrating the proper beta-lactam dosing regimen in septic critical OLT recipients undergoing CRRT?
Journal: Journal of critical care
Published: April 10, 2026
Impact of timing of aggressive joint PK/PD target attainment of continuous infusion piperacillin-tazobactam on early clinical response of febrile neutropenia to antimicrobial treatment: insights from a prospective, monocentric, observational study in pediatric hematopoietic stem cell recipients.
Journal: International journal of antimicrobial agents
Published: March 31, 2026
ARC in Critical Ill OLT Recipients: True Prevalence, Risk Factors, and Impact on Early Aggressive PK/PD Target Non-Attainment of CI Beta-Lactam Therapy for Posttransplant Gram-Negative Infections.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 19, 2026
Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 04, 2026
Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study.
Journal: JAC-antimicrobial resistance
Published: February 26, 2026
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients.
Journal: The Journal of antimicrobial chemotherapy
Published: February 11, 2026
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: A valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?
Journal: International journal of antimicrobial agents
Published: February 06, 2026
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction?
Journal: Antibiotics (Basel, Switzerland)
Published: February 06, 2026
Last Updated: 09/26/2026